An Aggressive angiomyxoma in a male patient: A rare case

Authors

  • Nita Damayanti Universitas Gadjah Mada
  • Niken Trisnowati Department of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia.
  • Carolina Kurniawati Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia Gedung Radiopoetro lantai 3, Jl. Farmako Sekip Utara, Senolowo, Sinduadi, Kec. Mlati, Kabupaten Sleman, Daerah Istimewa Yogyakarta 55281, Indonesia
  • Suwardjo Division Surgical Oncology, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia.

DOI:

https://doi.org/10.66344/jpad.31.4.2021.1732

Abstract

Aggressive angiomyxoma (AAM) is a rare mesenchymal tumor commonly affecting perineum of female, but also inflicting analogue area of male in lower incidence. We describe a 22-year-old man with a pedunculated, soft tumor, sized 10x5x7 cm in largest part, on his gluteal sinistra area.  The tumor was completely excised, and histology examination showed squamous epithelia, spindle- and stellate-shaped cells within myxoid stoma without mitotic figures, fibrosis in some area, and thick-walled blood vessels. No recurrence was observed until 1-year follow-up after surgery.

Downloads

Published

2022-03-29

How to Cite

1.
Damayanti N, Trisnowati N, Kurniawati C, Suwardjo. An Aggressive angiomyxoma in a male patient: A rare case. J Pak Assoc Dermatol [Internet]. 2022Mar.29 [cited 2026Apr.12];31(4):767-70. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1732

Issue

Vol. 31 No. 4 (2021): October - December

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.